List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 88 studies with search of: Cerebral Atrophy
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed A Clinical Study Evaluating the Effects of Memantine on Brain Atrophy in Alzheimer's Disease Patients
Condition: Alzheimer's Disease
Interventions: Drug: Memantine;   Drug: Placebo
2 Recruiting Sunphenon in Progressive Forms of Multiple Sclerosis
Condition: Primary or Secondary Chronic-Progressive Multiple Sclerosis
Interventions: Drug: Sunphenon EGCG;   Drug: Placebo
3 Recruiting Double Blind Placebo-Controlled Phase I/II Clinical Trial of Idebenone in Patients With Primary Progressive Multiple Sclerosis (IPPoMS)
Condition: Primary Progressive Multiple Sclerosis
Intervention: Drug: Idebenone
4 Recruiting Evaluating the Impact of Cerebral Ischemic And Degenerative Changes On Cognition
Condition: Cognitive Decline
Intervention:
5 Active, not recruiting ACCORD-MIND: Action to Control Cardiovascular Risk in Diabetes--Memory in Diabetes
Conditions: Atherosclerosis;   Cardiovascular Diseases;   Hypercholesterolemia;   Hypertension;   Diabetes Mellitus;   Coronary Disease
Interventions: Drug: hypoglycemic agents;   Drug: hydroxymethylglutaryl-CoA Reductase inhibitors;   Drug: antihypertensive agents;   Drug: fibrates
6 Recruiting Investigation of Simvastatin in Secondary Progressive Multiple Sclerosis
Condition: Secondary Progressive Multiple Sclerosis
Interventions: Drug: Simvastatin;   Drug: Placebo
7 Completed Fatigue in Multiple Sclerosis: Evaluated With 3 MRI and Transcranial Magnetic Stimulation
Conditions: Multiple Sclerosis;   Fatigue
Interventions: Drug: 3,4-diaminopyridine;   Drug: Placebo
8 Recruiting A Safety Study of Combination Treatment With Avonex and Placebo-Controlled Dosing of Topamax in Relapsing-Remitting Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Drug: Avonex and Topamax
9 Completed Study of Memantine in Assessment of Selected Measures of Volumetric Magnetic Resonance Imaging (MRI) and Cognition in Moderate AD (Alzheimer's Disease)
Condition: Alzheimer's Disease
Intervention: Drug: memantine HCl
10 Recruiting Flupirtine as Oral Treatment in Multiple Sclerosis
Condition: Relapsing Remitting Multiple Sclerosis
Interventions: Drug: Flupirtine;   Drug: Placebo
11 Active, not recruiting
Has Results 		A Phase II Study Comparing Low- and High-Dose Alemtuzumab and High-Dose Rebif® in Patients With Early, Active Relapsing-Remitting Multiple Sclerosis
Condition: Multiple Sclerosis, Relapsing-Remitting
Interventions: Biological: interferon beta-1a (Rebif®);   Biological: alemtuzumab
12 Completed Magnetic Stimulation Therapy for Treating Vascular Depression
Conditions: Depressive Disorder;   Depression
Interventions: Procedure: Repetitive transcranial magnetic stimulation (rTMS);   Drug: Citalopram;   Procedure: Sham rTMS
13 Completed A Randomised Controlled Trial of Neuroprotection With Lamotrigine in Secondary Progressive Multiple Sclerosis
Condition: Secondary Progressive Multiple Sclerosis
Intervention: Drug: Lamotrigine
14 Terminated Assessment Study of Steroid Effect in Relapsing Multiple Sclerosis Subjects Treated With Glatiramer Acetate
Condition: Relapsing Remitting Multiple Sclerosis
Intervention: Drug: Glatiramer Acetate
15 Recruiting The Neuroprotective Effect of Lamotrigine and Interferon Beta 1a in Patients With Relapsing-Remitting Multiple Sclerosis
Condition: Relapsing-Remitting Multiple Sclerosis
Intervention: Drug: lamotrigine
16 Active, not recruiting Far Infrared Irradiation for the Management, Control and Treatment of Frontotemporal Dementia
Condition: Pick Disease of the Brain
Intervention: Radiation: Radiation: Far Infrared Radiation (5μm to 20μm wavelength)
17 Recruiting A Study of Orally Administered BGC20-0134 (Structured Lipid) in Patients With Relapsing Remitting Multiple Sclerosis (RRMS)
Condition: Relapsing Remitting Multiple Sclerosis
Interventions: Drug: Pleneva TM BGC20-0134;   Drug: Placebo
18 Completed Atorvastatin 40 mg in Patients With Relapsing-Remitting Multiple Sclerosis Treated With Interferon-Beta-1b
Condition: Multiple Sclerosis
Interventions: Drug: Interferon beta 1b;   Drug: Atorvastatin
19 Recruiting Determinants of Cognitive Impairment After Acute Coronary Syndrome
Condition: Coronary Syndrome
Intervention: Other: Brain MRI and cerebral perfusion scintigraphy
20 Recruiting A Combination Trial of Copaxone Plus Estriol in Relapsing Remitting Multiple Sclerosis (RRMS)
Condition: Relapsing Remitting Multiple Sclerosis
Interventions: Drug: Estriol;   Drug: Placebo

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services